Petros Grivas on Twitter

We continue the pursuit to develop validated biomarkers predictive of response to neoadjuvant chemotherapy and checkpoint inhibitors. Dr. Kala Sridhar covered the topic very well at #AUA23, a lot of promise but we lack biomarkers with established clinical utility

Read the full article here

Related Articles